Clifford Stocks
Clifford Stocks is the founder of OncoResponse and currently leads the company. He previously served as Executive Officer and Director at OncoResponse Inc.
-
OncoResponse Executive Officer, Director 2017–present, Chief Executive Officer 2015–present · current
-
Theraclone Sciences Chief Executive Officer 2011–2016 · past
-
Calistoga Pharmaceuticals (acquired by Gilead 2011) Chief Business Officer 2009–2011 · past
-
ICOS Corporation (acquired by Lilly for $2.3 Billion in 2007) Vice President, Business Development 1992–2007 · past
-
Booz Allen & Hamilton Management Consultant 1989–1991 · past
-
University of Chicago Department of Molecular Genetics and Cell Biology (MGCB) Senior Research Technologist 1987–1989 · past
Education
-
The University of Chicago Booth School of Business MBA, Statistics; Operations; Leadership · 1986–1989
-
University of Utah B.S., Biology · 1976–1980